Clinical Study
Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy
Table 7
Multivariate prognostic analysis.
| Prognostic factors | LC | OS | HR | | HR | |
| T stage | 4.592 | <0.001 | 0.955 | 0.061 | N stage | 0.662 | 0.098 | 5.258 | <0.001 | GTVnx volume | 1.825 | 0.064 | 3.846 | <0.001 | Radiotherapy interruption | 5.481 | <0.001 | 4.233 | <0.001 | HGB | 0.339 | 0.463 | 1.905 | 0.002 | Percentage of weight loss | 0.229 | 0.621 | 1.018 | 0.033 | Chemo. or not | 0.683 | 0.221 | 4.353 | <0.001 |
|
|
HGB: hemoglobin; LC: local-regional control rates; OS: overall survival rate; HR: hazards ratio.
|